Literature DB >> 13892762

Experimental allergic encephalomyelitis: comparison of protective effects of prednisolone and corticotrophin.

E J FIELD, H MILLER.   

Abstract

Entities:  

Keywords:  ALLERGY/experimental; CORTICOTROPIN/pharmacology; ENCEPHALOMYELITIS/experimental; PREDNISOLONE/pharmacology

Mesh：

Substances：

Year:  1962        PMID： 13892762      PMCID： PMC1958036          DOI： 10.1136/bmj.1.5281.843

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  5 in total

1.  Basic considerations in the use of anti-inflammatory steroids in neurological diseases.

Authors:  I E BUSH
Journal:  Proc R Soc Med       Date:  1961-07

2.  [Experimental encephalomyelitis in guinea pigs].

Authors:  J ROSS; H J COLMANT; P BOHM
Journal:  Dtsch Z Nervenheilkd       Date:  1958

3.  ACTH and cortisone in the treatment of multiple sclerosis.

Authors:  G VON REIS; E SAHLGREN; B JONSSON
Journal:  Acta Psychiatr Neurol Scand       Date:  1953

4.  Multiple sclerosis. Treatment of acute exacerbations with corticotrophin (A.C.T.H.).

Authors:  H MILLER; D J NEWELL; A RIDLEY
Journal:  Lancet       Date:  1961-11-18       Impact factor: 79.321

5.  Action of adrenocorticotropic hormone (ACTH) in experimental allergic encephalomyelitis of the guinea pig.

Authors:  A W MOYER; G A JERVIS; J BLACK; H KOPROWSKI; H R COX
Journal:  Proc Soc Exp Biol Med       Date:  1950-11
  5 in total
  4 in total

Review 1.  [ACTH AND CORTICOID TREATMENT OF NEUROLOGIC DISEASES].

Authors:  H BAMMER
Journal:  Dtsch Z Nervenheilkd       Date:  1963-07-10

Review 2.  Adrenal steroid therapy in neurological disease. Part I.

Authors:  A A Eisen; J W Norris
Journal:  Can Med Assoc J       Date:  1969-01-04       Impact factor: 8.262

3.  Prevention and reversal of adoptively transferred, chronic relapsing experimental autoimmune encephalomyelitis with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplantation.

Authors:  D M Karussis; U Vourka-Karussis; D Lehmann; H Ovadia; R Mizrachi-Koll; A Ben-Nun; O Abramsky; S Slavin
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

4.  Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator linomide (quinoline-3-carboxamide).

Authors:  D M Karussis; D Lehmann; S Slavin; U Vourka-Karussis; R Mizrachi-Koll; H Ovadia; T Kalland; O Abramsky
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.